Access this stock data via API
Subscribe
CSPC Pharmaceutical Group Ltd.
0
0
0%

Financials

Income statement

Fundamentals currency is CNY
Fiscal date 2024 2023 2022 2021
Total reported revenue 32.0B 34.3B 30.9B 27.9B
Cost of revenue 9.6B 10.1B 8.7B 6.7B
Gross profit 22.4B 24.2B 22.3B 21.1B
Operating expense
Research & development 5.7B 5.3B 4.0B 3.4B
Selling general and admin 10.7B 11.3B 11.5B 11.5B
Other operating expenses 108.2M
Operating income 5.9B 7.7B 6.8B 6.2B
Non operating interest income
Income
Expense 48.2M 28.3M 24.9M 7.7M
Other income expense
Pretax income 6.2B 8.1B 7.6B 6.8B
Tax provision 1.4B 1.4B 1.4B 1.2B
Net income 4.8B 6.6B 6.2B 5.7B
Basic EPS 0.4 0.5 0.5 0.5
Diluted EPS 0.4 0.5 0.5 0.5
Basic average shares 13.0B 13.0B 11.2B 11.2B
Diluted average shares 13.0B 13.0B 11.2B 11.2B
EBITDA 7.7B 9.3B 8.6B 7.7B
Net income from continuing op. 6.2B 8.1B 7.6B 6.8B
Minority interests -10.8M -199.4M -140.7M -82.9M
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 7 hours 20 minutes

01:39
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
09:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 16:10
All times are displayed in the Asia/Hong_Kong timezone (HKT, UTC+08:00).